Building towards a standardised approach to biocorrosion studies: a review of factors influencing Mg corrosion in vitro pertinent to in vivo corrosion
Source abstract
Abstract
The factors that influence magnesium (Mg) corrosion in vitro are systematically evaluated from a review of the relevant literature. We analysed the influence of the following factors on Mg biocorrosion in vitro : (i) inorganic ions, including both anions and cations, (ii) organic components such as proteins, amino acids and vitamins, and (iii) experimental parameters such as temperature, pH, buffer system and flow rate. Considerations and recommendations towards a standardised approach to in vitro biocorrosion testing are given. Several potential simulated body fluids are recommended. Implementing a standardised approach to experimental parameters has the potential to significantly reduce variability between in vitro biocorrosion tests, and to help build towards a methodology that accurately and consistently mimics in vivo corrosion. However, there are also knowledge gaps with regard to how best to characterise the in vivo environment and corrosion mechanism. The assumption that blood plasma is the correct bodily fluid upon which to base in vitro methodologies is examined, and factors that influence the corrosion mechanism in vivo , such as specimen encapsulation, bear consideration for further studies.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Magnesium Alloys: Properties and Applications · Hydrogen Storage and Materials · Corrosion Behavior and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Zheng YF, Gu XN, Witte F. Biodegradable metals. Mater Sci Eng-R-Rep, 2014, 77: 1–3410.1016/j.mser.2014.01.001 ↗
2. Staiger MP, Pietak AM, Huadmai J, et al. Magnesium and its alloys as orthopedic biomaterials: a review. Biomaterials, 2006, 27: 1728–173410.1016/j.biomaterials.2005.10.003 ↗
3. Waizy H, Seitz JM, Reifenrath J, et al. Biodegradable magnesium implants for orthopedic applications. J Mater Sci, 2013, 48: 39–5010.1007/s10853-012-6572-2 ↗
4. Erbel R, Di Mario C, Bartunek J, et al. Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet, 2007, 369: 1869–187510.1016/S0140-6736(07)60853-8 ↗
5. Seitz JM, Durisin M, Goldman J, et al. Recent advances in biodegradable metals for medical sutures: a critical review. Adv Healthcare Mater, 2015, 4: 1915–193610.1002/adhm.201500189 ↗
6. Eddy Jai Poinern G, Brundavanam S, Fawcett D. Biomedical magnesium alloys: a review of material properties, surface modifications and potential as a biodegradable orthopaedic implant. Am J Biomed Eng, 2012, 2: 218–24010.5923/j.ajbe.20120206.02 ↗
7. Chaya A, Yoshizawa S, Verdelis K, et al. In vivo study of magnesium plate and screw degradation and bone fracture healing. Acta Biomater, 2015, 18: 262–26910.1016/j.actbio.2015.02.010 ↗
8. Castellani C, Lindtner RA, Hausbrandt P, et al. Bone–implant interface strength and osseointegration: biodegradable magnesium alloy versus standard titanium control. Acta Biomater, 2011, 7: 432–44010.1016/j.actbio.2010.08.020 ↗
9. Zhang E, Xu L, Yu G, et al. In vivo evaluation of biodegradable magnesium alloy bone implant in the first 6 months implantation. J Biomed Mater Res, 2009, 90A: 882–89310.1002/jbm.a.32132 ↗
10. Erne P, Schier M, Resink TJ. The road to bioabsorbable stents: reaching clinical reality? Cardiovasc Intervent Radiol, 2006, 29: 11–1610.1007/s00270-004-0341-9 ↗
11. Moravej M, Mantovani D. Biodegradable metals for cardiovascular stent application: interests and new opportunities. Int J Mol Sci, 2011, 12: 4250–427010.3390/ijms12074250 ↗
12. Arsiwala A, Desai P, Patravale V. Recent advances in micro/nanoscale biomedical implants. J Control Release, 2014, 189: 25–4510.1016/j.jconrel.2014.06.021 ↗
13. Lee JW, Han HS, Han KJ, et al. Long-term clinical study and multiscale analysis of in vivo biodegradation mechanism of Mg alloy. Proc Natl Acad Sci USA, 2016, 113: 716–72110.1073/pnas.1518238113 ↗
14. Haude M, Erbel R, Erne P, et al. TCT-38 Three-year clinical data of the BIOSOLVE-I Study with the paclitaxel-eluting bioabsorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis. J Am College Cardiology, 2013, 62: B1310.1016/j.jacc.2013.08.768 ↗
15. Haude M, Erbel R, Erne P, et al. TCT-625 long term clinical data of the BIOSOLVE-I study with the paclitaxel-eluting absorbable magnesium scaffold (DREAMS) and multi-modality imaging analysis. J Am College Cardiology, 2014, 64: B182–B18310.1016/j.jacc.2014.07.690 ↗
16. Seitz JM, Lucas A, Kirschner M. Magnesium-based compression screws: a novelty in the clinical use of implants. JOM, 2016, 68: 1177–118210.1007/s11837-015-1773-1 ↗
17. Haude M, Ince H, Abizaid A, et al. Sustained safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de novo coronary lesions: 12-month clinical results and angiographic findings of the BIOSOLVE-II first-in-man trial. Eur Heart J, 2016, 37: 2701–270910.1093/eurheartj/ehw196 ↗
18. Zhang Y, Xu J, Ruan YC, et al. Implant-derived magnesium induces local neuronal production of CGRP to improve bonefracture healing in rats. Nat Med, 2016, 22: 1160–116910.1038/nm.4162 ↗
19. Ohsawa I, Ishikawa M, Takahashi K, et al. Hydrogen acts as a therapeutic antioxidant by selectively reducing cytotoxic oxygen radicals. Nat Med, 2007, 13: 688–69410.1038/nm1577 ↗
20. Chen X. Magnesium-based implants: beyond fixators. J Orthopaedic Translation, 2017, 10: 1–410.1016/j.jot.2016.12.001 ↗
21. Atrens A, Liu M, Zainal Abidin NI. Corrosion mechanism applicable to biodegradable magnesium implants. Mater Sci Eng-B, 2011, 176: 1609–163610.1016/j.mseb.2010.12.017 ↗
22. Song G, Atrens A. Understanding magnesium corrosion—a framework for improved alloy performance. Adv Eng Mater, 2003, 5: 837–85810.1002/adem.200310405 ↗
23. Witte F. The history of biodegradable magnesium implants: a review. Acta Biomater, 2010, 6: 1680–169210.1016/j.actbio.2010.02.028 ↗
24. Zainal Abidin NI, Rolfe B, Owen H, et al. The in vivo and in vitro corrosion of high-purity magnesium and magnesium alloys WZ21 and AZ91. Corrosion Sci, 2013, 75: 354–36610.1016/j.corsci.2013.06.019 ↗
25. Hofstetter J, Becker M, Martinelli E, et al. High-strength low-alloy (HSLA) Mg–Zn–Ca Alloys with excellent biodegradation performance. JOM, 2014, 66: 566–57210.1007/s11837-014-0875-5 ↗
26. Zhao D, Witte F, Lu F, et al. Current status on clinical applications of magnesium-based orthopaedic implants: a review from clinical translational perspective. Biomaterials, 2017, 112: 287–30210.1016/j.biomaterials.2016.10.017 ↗
27. Bobe K, Willbold E, Morgenthal I, et al. In vitro and in vivo evaluation of biodegradable, open-porous scaffolds made of sintered magnesium W4 short fibres. Acta Biomater, 2013, 9: 8611–862310.1016/j.actbio.2013.03.035 ↗
28. Gu XN, Xie XH, Li N, et al. In vitro and in vivo studies on a Mg–Sr binary alloy system developed as a new kind of biodegradable metal. Acta Biomater, 2012, 8: 2360–237410.1016/j.actbio.2012.02.018 ↗
29. Hiromoto S, Inoue M, Taguchi T, et al. In vitro and in vivo biocompatibility and corrosion behaviour of a bioabsorbable magnesium alloy coated with octacalcium phosphate and hydroxyapatite. Acta Biomater, 2015, 11: 520–53010.1016/j.actbio.2014.09.026 ↗
30. Jang Y, Collins B, Sankar J, et al. Effect of biologically relevant ions on the corrosion products formed on alloy AZ31B: an improved understanding of magnesium corrosion. Acta Biomater, 2013, 9: 8761–877010.1016/j.actbio.2013.03.026 ↗
31. Lin X, Tan L, Zhang Q, et al. The in vitro degradation process and biocompatibility of a ZK60 magnesium alloy with a forsteritecontaining micro-arc oxidation coating. Acta Biomater, 2013, 9: 8631–864210.1016/j.actbio.2012.12.016 ↗
32. Martinez Sanchez AH, Luthringer BJC, Feyerabend F, et al. Mg and Mg alloys: how comparable are in vitro and in vivo corrosion rates? A review. Acta Biomater, 2015, 13: 16–3110.1016/j.actbio.2014.11.048 ↗
33. Wang HX, Guan SK, Wang X, et al. In vitro degradation and mechanical integrity of Mg–Zn–Ca alloy coated with Ca-deficient hydroxyapatite by the pulse electrodeposition process. Acta Biomater, 2010, 6: 1743–174810.1016/j.actbio.2009.12.009 ↗
34. Zheng YF, Gu XN, Xi YL, et al. In vitro degradation and cytotoxicity of Mg/Ca composites produced by powder metallurgy. Acta Biomater, 2010, 6: 1783–179110.1016/j.actbio.2009.10.009 ↗
35. Zhou WR, Zheng YF, Leeflang MA, et al. Mechanical property, biocorrosion and in vitro biocompatibility evaluations of Mg–Li–(Al)–(RE) alloys for future cardiovascular stent application. Acta Biomater, 2013, 9: 8488–849810.1016/j.actbio.2013.01.032 ↗
36. Johnston S, Shi Z, Atrens A. The influence of pH on the corrosion rate of high-purity Mg, AZ91 and ZE41 in bicarbonate buffered Hanks’ solution. Corrosion Sci, 2015, 101: 182–19210.1016/j.corsci.2015.09.018 ↗
37. Johnston S, Shi Z, Dargusch MS, et al. Influence of surface condition on the corrosion of ultra-high-purity Mg alloy wire. Corrosion Sci, 2016, 108: 66–7510.1016/j.corsci.2016.03.007 ↗
38. Kirkland NT, Lespagnol J, Birbilis N, et al. A survey of biocorrosion rates of magnesium alloys. Corrosion Sci, 2010, 52: 287–29110.1016/j.corsci.2009.09.033 ↗
39. Johnston S, Shi Z, Hoe C, et al. The influence of two common sterilization techniques on the corrosion of Mg and its alloys for biomedical applications. J Biomed Mater Res, 2017, doi: 10.1002/jbm.b.34004
40. Li Y, Wen C, Mushahary D, et al. Mg–Zr–Sr alloys as biodegradable implant materials. Acta Biomater, 2012, 8: 3177–318810.1016/j.actbio.2012.04.028 ↗
41. Staiger MP, Feyerabend F, Willumeit R, et al. Summary of the panel discussions at the 2nd Symposium on Biodegradable Metals, Maratea, Italy, 2010. Mater Sci Eng-B, 2010, 176: 1596–1599
42. Witte F, Fischer J, Nellesen J, et al. In vitro and in vivo corrosion measurements of magnesium alloys. Biomaterials, 2006, 27: 1013–101810.1016/j.biomaterials.2005.07.037 ↗
43. Marco I, Feyerabend F, Willumeit-Römer R, et al. Influence of testing environment on the degradation behavior of magnesium alloys for bioabsorbable implants. In: TMS 2015, 144th Annual Meeting & Exhibition, 2015, 497–506
44. Choudhary L, Singh Raman RK. Magnesium alloys as body implants: Fracture mechanism under dynamic and static loadings in a physiological environment. Acta Biomater, 2012, 8: 916–92310.1016/j.actbio.2011.10.031 ↗
45. El-Taib Heakal F, Shehata OS, Tantawy NS. Degradation behaviour of AZ80E magnesium alloy exposed to phosphate buffer saline medium. Corrosion Sci, 2014, 86: 285–29410.1016/j.corsci.2014.06.008 ↗
46. Carboneras M, García-Alonso MC, Escudero ML. Biodegradation kinetics of modified magnesium-based materials in cell culture medium. Corrosion Sci, 2011, 53: 1433–143910.1016/j.corsci.2011.01.014 ↗
47. Vojtěch D, Kubásek J, Čapek J. Comparative mechanical and corrosion studies on magnesium, zinc and iron alloys as biodegradable metals. Mater Tehnol, 2015, 49: 877–88210.17222/mit.2014.129 ↗
48. Walker J, Shadanbaz S, Kirkland NT, et al. Magnesium alloys: Predicting in vivo corrosion with in vitro immersion testing. J Biomed Mater Res, 2012, 100B: 1134–114110.1002/jbm.b.32680 ↗
49. Witecka A, Bogucka A, Yamamoto A, et al. In vitro degradation of ZM21 magnesium alloy in simulated body fluids. Mater Sci Eng-C, 2016, 65: 59–6910.1016/j.msec.2016.04.019 ↗
50. Marco I, Myrissa A, Martinelli E, et al. In vivo and in vitro degradation comparison of pure Mg, Mg-10Gd and Mg-2Ag: a short term study. eCM, 2017, 33: 90–10410.22203/eCM.v033a07 ↗
51. Taltavull C, Shi Z, Torres B, et al. Influence of the chloride ion concentration on the corrosion of high-purity Mg, ZE41 and AZ91 in buffered Hank’s solution. J Mater Sci-Mater Med, 2014, 25: 329–34510.1007/s10856-013-5087-y ↗
52. Gu X, Zheng Y, Cheng Y, et al. In vitro corrosion and biocompatibility of binary magnesium alloys. Biomaterials, 2009, 30: 484–49810.1016/j.biomaterials.2008.10.021 ↗
53. ASTM WK52640. New Guide for In-Vitro Degradation Testing of Absorbable Metals. ASTM International, 2016
54. Atrens A, Song GL, Liu M, et al. Review of recent developments in the field of magnesium corrosion. Adv Eng Mater, 2015, 17: 400–45310.1002/adem.201400434 ↗
55. Atrens A, Song GL, Cao F, et al. Advances in Mg corrosion and research suggestions. J Magnesium Alloys, 2013, 1: 177–20010.1016/j.jma.2013.09.003 ↗
56. Song GL, Atrens A. Corrosion mechanisms of magnesium alloys. Adv Eng Mater, 1999, 1: 11–3310.1002/(SICI)1527-2648(199909)1:1<11::AID-ADEM11>3.0.CO;2-N ↗
57. Liu M, Schmutz P, Uggowitzer PJ, et al. The influence of yttrium (Y) on the corrosion of Mg–Y binary alloys. Corrosion Sci, 2010, 52: 3687–370110.1016/j.corsci.2010.07.019 ↗
58. Kirkland NT, Birbilis N, Staiger MP. Assessing the corrosion of biodegradable magnesium implants: a critical review of current methodologies and their limitations. Acta Biomater, 2012, 8: 925–93610.1016/j.actbio.2011.11.014 ↗
59. Xin Y, Huo K, Tao H, et al. Influence of aggressive ions on the degradation behavior of biomedical magnesium alloy in physiological environment. Acta Biomater, 2008, 4: 2008–201510.1016/j.actbio.2008.05.014 ↗
60. Wang J, Giridharan V, Shanov V, et al. Flow-induced corrosion behavior of absorbable magnesium-based stents. Acta Biomater, 2014, 10: 5213–522310.1016/j.actbio.2014.08.034 ↗
61. Krebs HA. Chemical composition of blood plasma and serum. Annu Rev Biochem, 1950, 19: 409–43010.1146/annurev.bi.19.070150.002205 ↗
62. Neville A. Chloride attack of reinforced concrete: an overview. Mater Struct, 1995, 28: 63–7010.1007/BF02473172 ↗
63. Jones DA. Principles and Prevention of Corrosion. Upper Saddle River: Pearson, 1996
64. Jones DDG, Masterson HG. Effect of chloride concentration on the aqueous corrosion of a magnesium alloy. Nature, 1961, 191: 165–16610.1038/191165a0 ↗
65. Zhao MC, Liu M, Song GL, et al. Influence of pH and chloride ion concentration on the corrosion of Mg alloy ZE41. Corrosion Sci, 2008, 50: 3168–317810.1016/j.corsci.2008.08.023 ↗
66. Mueller WD, Lucia Nascimento M, Lorenzo de Mele MF. Critical discussion of the results from different corrosion studies of Mg and Mg alloys for biomaterial applications. Acta Biomater, 2010, 6: 1749–175510.1016/j.actbio.2009.12.048 ↗
67. Ma W, Liu Y, Wang W, et al. Effects of electrolyte component in simulated body fluid on the corrosion behavior and mechanical integrity of magnesium. Corrosion Sci, 2015, 98: 201–21010.1016/j.corsci.2015.05.012 ↗
68. Wasserman K, Whipp BJ, Koyl S, et al. Anaerobic threshold and respiratory gas exchange during exercise. J Appl Physiol, 1973, 35: 236–24310.1152/jappl.1973.35.2.236 ↗
69. Xin Y, Hu T, Chu PK. Degradation behaviour of pure magnesium in simulated body fluids with different concentrations of HCO3–. Corrosion Sci, 2011, 53: 1522–152810.1016/j.corsci.2011.01.015 ↗
70. Xin Y, Chu PK. Influence of Tris in simulated body fluid on degradation behavior of pure magnesium. Mater Chem Phys, 2010, 124: 33–3510.1016/j.matchemphys.2010.07.010 ↗
71. Agha NA, Feyerabend F, Mihailova B, et al. Magnesium degradation influenced by buffering salts in concentrations typical of in vitro and in vivo models. Mater Sci Eng-C, 2016, 58: 817–82510.1016/j.msec.2015.09.067 ↗
72. Kirkland NT, Waterman J, Birbilis N, et al. Buffer-regulated biocorrosion of pure magnesium. J Mater Sci-Mater Med, 2012, 23: 283–29110.1007/s10856-011-4517-y ↗
73. Bryant JC. Earle’s balanced salt solution: Preparation of the saline. TCA manual/Tissue Culture Association, 1975, 1: 185–18710.1007/BF00916996 ↗
74. Revie RW. Uhlig’s Corrosion Handbook (3rd Ed). Hoboken: John Wiley & Sons, 201110.1002/9780470872864 ↗
75. Abidin NIZ, Atrens AD, Martin D, et al. Corrosion of high purity Mg, Mg2Zn0.2Mn, ZE41 and AZ91 in Hank’s solution at 37°C. Corrosion Sci, 2011, 53: 3542–355610.1016/j.corsci.2011.06.030 ↗
76. Yamamoto A, Hiromoto S. Effect of inorganic salts, amino acids and proteins on the degradation of pure magnesium in vitro. Mater Sci Eng-C, 2009, 29: 1559–156810.1016/j.msec.2008.12.015 ↗
77. Ning C, Zhou L, Zhu Y, et al. Influence of surrounding cations on the surface degradation of magnesium alloy implants under a compressive pressure. Langmuir, 2015, 31: 13561–1357010.1021/acs.langmuir.5b03699 ↗
78. Dill D, Costill DL. Calculation of percentage changes in volumes of blood, plasma, and red cells in dehydration. J Appl Physiol, 1974, 37: 247–24810.1152/jappl.1974.37.2.247 ↗
79. Adkins JN, Varnum SM, Auberry KJ, et al. Toward a human blood serum proteome. Mol Cell Proteomics, 2002, 1: 947–95510.1074/mcp.M200066-MCP200 ↗
80. Kragh-Hansen U. Molecular aspects of ligand binding to serum albumin. Pharmacol Rev, 1981, 33: 17–5310.1016/S0031-6997(25)06849-8 ↗
81. Liu CL, Wang YJ, Zeng RC, et al. In vitro corrosion degradation behaviour of Mg–Ca alloy in the presence of albumin. Corrosion Sci, 2010, 52: 3341–334710.1016/j.corsci.2010.06.003 ↗
82. Gu XN, Zheng YF, Chen LJ. Influence of artificial biological fluid composition on the biocorrosion of potential orthopedic Mg–Ca, AZ31, AZ91 alloys. Biomed Mater, 2009, 4: 06501110.1088/1748-6041/4/6/065011 ↗
83. Liu C, Xin Y, Tian X, et al. Degradation susceptibility of surgical magnesium alloy in artificial biological fluid containing albumin. J Mater Res, 2007, 22: 1806–181410.1557/jmr.2007.0241 ↗
84. Zhang J, Kong N, Shi Y, et al. Influence of proteins and cells on in vitro corrosion of Mg–Nd–Zn–Zr alloy. Corrosion Sci, 2014, 85: 477–48110.1016/j.corsci.2014.04.020 ↗
85. Törne K, Örnberg A, Weissenrieder J. The influence of buffer system and biological fluids on the degradation of magnesium. J Biomed Mater Res, 2016, 105: 1490–150210.1002/jbm.b.33685 ↗
86. Törne K, Larsson M, Norlin A, et al. Degradation of zinc in saline solutions, plasma, and whole blood. J Biomed Mater Res, 2016, 104: 1141–115110.1002/jbm.b.33458 ↗
87. Gray-Munro JE, Strong M. A study on the interfacial chemistry of magnesium hydroxide surfaces in aqueous phosphate solutions: influence of Ca2+, Cl− and protein. J Colloid Interface Sci, 2013, 393: 421–42810.1016/j.jcis.2012.10.047 ↗
88. Johnson I, Jiang W, Liu H. The effects of serum proteins on magnesium alloy degradation in vitro. Sci Rep, 2017, 7: 1433510.1038/s41598-017-14479-6 ↗
89. Aldrich JE, Burtis CA, Ashwood ER, et al. Tietz Fundamentals of Clinical Chemistry. Philadelphia: WB Saunders, 1996
90. Zeng RC, Li XT, Li SQ, et al. In vitro degradation of pure Mg in response to glucose. Sci Rep, 2015, 5: 1302610.1038/srep13026 ↗
91. Cui LY, Li XT, Zeng RC, et al. In vitro corrosion of Mg–Ca alloy —The influence of glucose content. Front Mater Sci, 2017, 11: 284–29510.1007/s11706-017-0391-y ↗
92. Wang Y, Cui LY, Zeng RC, et al. In vitro degradation of pure magnesium—the effects of glucose and/or amino acid. Materials, 2017, 10: 72510.3390/ma10070725 ↗
93. Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Seminars Immunol, 2008, 20: 86–10010.1016/j.smim.2007.11.004 ↗
94. Anderson JM. Inflammatory response to implants. ASAIO J, 1988, 34: 101–10710.1097/00002480-198804000-00005 ↗
95. Ovchinnikov DA. Macrophages in the embryo and beyond: much more than just giant phagocytes. genesis, 2008, 46: 447–46210.1002/dvg.20417 ↗
96. Mu Y, Kobayashi T, Sumita M, et al. Metal ion release from titanium with active oxygen species generated by rat macrophages in vitro. J Biomed Mater Res, 2000, 49: 238–24310.1002/(SICI)1097-4636(200002)49:2<238::AID-JBM12>3.0.CO;2-J ↗
97. Zhang J, Hiromoto S, Yamazaki T, et al. Effect of macrophages on in vitro corrosion behavior of magnesium alloy. J Biomed Mater Res, 2016, 104: 2476–248710.1002/jbm.a.35788 ↗
98. Geis-Gerstorfer J, Schille C, Schweizer E, et al. Blood triggered corrosion of magnesium alloys. Mater Sci Eng-B, 2011, 176: 1761–176610.1016/j.mseb.2011.06.006 ↗
99. Lock JY, Wyatt E, Upadhyayula S, et al. Degradation and antibacterial properties of magnesium alloys in artificial urine for potential resorbable ureteral stent applications. J Biomed Mater Res, 2014, 102: 781–79210.1002/jbm.a.34741 ↗
100. Liu Y, Zheng S, Li N, et al. In vivo response of AZ31 alloy as biliary stents: a 6 months evaluation in rabbits. Sci Rep, 2017, 7: 4018410.1038/srep40184 ↗